Anti-CD8 [14] mAb

Clone 14 is recommended for: the detection of immunoregulatory T cell subset imbalances in autoimmune disorders and immunodeficiency states, categorisation of T cell acute lymphoblastic leukaemia and lymphoblastic lymphoma in conjunction with other antigens and determination of CD4/CD8 ratios in immune deficiencies, rheumatoid arthritis and multiple sclerosis.

Contributors

Inventor Institute
Nancy Hogg Cancer Research UK, London Research Institute: Lincoln's Inn Fields
SKU: 151035
Product description: Clone 14 is recommended for: the detection of immunoregulatory T cell subset imbalances in autoimmune disorders and immunodeficiency states, categorisation of T cell acute lymphoblastic leukaemia and lymphoblastic lymphoma in conjunction with other antigens and determination of CD4/CD8 ratios in immune deficiencies, rheumatoid arthritis and multiple sclerosis.
Alternate name: Leu2
Conjugation: Unconjugated
Isotype: IgG1
Immunogen: Fibronectin-purified human monocytes
Myeloma used: Sp2/0-Ag14
Cat. #: 151035
Provenance and Ownership: The Anti-CD8 14 mAb is owned by Cancer Research UK. CancerTools supplies the Anti-CD8 14 mAb under licence from Cancer Research UK and is the authorised source for its distribution. Sourcing Anti-CD8 14 mAb directly from the IP owner ensures authenticity, provenance and compliance with all applicable licensing and research use requirements.
Tool sub type: Primary antibody
Unit size: 100 ug
Research Fields: Cancer; Immunology; Stem cell biology
Application: ELISA ; FACS ; IHC ; IP
Target: CD8
Reactivity: Human
Clone: 14
Host: Mouse
Class: Monoclonal
Target background: CD8 is a T cell co-receptor that recognises, together with the T cell receptor, MHC class I molecules. CD8 is present on human suppressor / cytotoxic T cells, 30% of circulating T cells. Clone 14 is recommended for: the detection of immunoregulatory T cell subset imbalances in autoimmune disorders and immunodeficiency states, categorisation of T cell acute lymphoblastic leukaemia and lymphoblastic lymphoma in conjunction with other antigens and determination of CD4/CD8 ratios in immune deficiencies, rheumatoid arthritis and multiple sclerosis.
Format: Liquid
Concentration: 1 mg/ml
Storage buffer: PBS with 0.02% azide
Storage conditions: -15° C to -25° C
Shipping conditions: Dry ice
References:

Hogg et al. 1999. J Clin Invest. 103(1):97-106. PMID: 9884339.

Images

View Gallery
Adapted from Xiao F; Ma L; Zhao M; Huang G; Mirenda V; Dorling A; Lechler R; Lombardi G. Ex vivo expanded human regulatory T cells delay islet allograft rejection via inhibiting islet-derived monocyte chemoattractant protein-1 production in CD34+ stem cells-reconstituted NOD-scid IL2r?null mice. PLoS One. 2014 Mar 3;9(3)

Related Tools for Antibodies

Cat. # Tool Name
151027 Anti-HSVICP8 [10A3] Key Info View Tool
151030 Anti-Progesterone [11P14] Key Info View Tool
151033 Anti-HSVUL42 [13C9] Key Info View Tool
151036 Anti-ICAM1 [15.2] Key Info View Tool
151041 Anti-LewisX [28] Key Info View Tool

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.